Cidara Therapeutics
CDTX
CDTX was delisted on the 6th of January, 2026.
54 hedge funds and large institutions have $89.3M invested in Cidara Therapeutics in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 6 closing their positions.
36% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 14
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.01% less ownership
Funds ownership: 3.42% → 3.41% (-0.01%)
7% less funds holding
Funds holding: 58 → 54 (-4)
25% less capital invested
Capital invested by funds: $119M → $89.3M (-$29.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.01M |
| 2 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$1.35M |
| 3 |
Millennium Management
New York
|
+$1.31M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.08M |
| 5 |
WFI
West Family Investments
Carlsbad,
California
|
+$878K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$2.73M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.01M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$800K |
| 4 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$440K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$351K |
CDTX Hedge Fund Activity: Q1 2017 in Review
54 of the 4,033 institutional investors tracked by Wall St. Rank reported a position in Cidara Therapeutics (CDTX) for Q1 2017, worth a combined $89.3M — down 25% from $119M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CDTX positions and 6 closed out — a net gain of 1 holder — while 19 added to existing stakes and 14 trimmed.
The largest buyer was BlackRock, adding an estimated $5.01M. The largest seller was AWM Investment Company, exiting entirely with an estimated $2.73M sold.
- 54 institutional investors held Cidara Therapeutics (CDTX) as of Q1 2017, down from 58 in Q4 2016.
- Funds reported $89.3M of Cidara Therapeutics stock for Q1 2017, down 25% quarter-over-quarter.
- 7 funds opened new Cidara Therapeutics positions in Q1 2017 and 6 closed out, a net change of +1 holder.
- The largest Cidara Therapeutics buyer in Q1 2017 was BlackRock, an estimated $5.01M added.
- The largest Cidara Therapeutics seller in Q1 2017 was AWM Investment Company, an estimated $2.73M sold.
Based on aggregated 13F filings for Q1 2017.